{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:36:05Z","timestamp":1794072965803,"version":"4.8.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Using separate adeno-associated viral 2 (AAV2) vectors to deliver the heavy and light chains of factor VIII (FVIII) we have overcome the packaging limitations of AAV, achieving phenotypic correction of hemophilia A in mice. AAV vectors were constructed that use a liver-specific promoter and the cDNA sequences of either the human or canine heavy and light chains of FVIII. After intraportal vein injection of these vectors in hemophilia-A mice, therapeutic to superphysiologic levels of active FVIII were achieved in plasma in a dose-dependent manner. Phenotypic correction of the bleeding diathesis was demonstrated by survival of all treated mice after tail clipping. Biochemical analysis demonstrated lower levels of heavy-chain (25- to 100-fold) compared with light-chain protein in the plasma of treated animals. Differences in gene transfer and transcription did not account for the differences in protein expression. We hypothesize that improvements in FVIII activity could be achieved by improvements in FVIII heavy-chain expression. This work demonstrates that cotransduction of liver with AAV vectors expressing the heavy and light chains of FVIII corrects hemophilia A in vivo, providing an alternative approach to the use of a single vector. This strategy may potentially be useful for other large therapeutic proteins that contain functionally distinct domains.<\/jats:p>","DOI":"10.1182\/blood-2003-01-0222","type":"journal-article","created":{"date-parts":[[2003,8,5]],"date-time":"2003-08-05T00:29:48Z","timestamp":1060043388000},"page":"3919-3926","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII"],"prefix":"10.1182","volume":"102","author":[{"given":"Ciaran D.","family":"Scallan","sequence":"first","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyao","family":"Liu","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Parker","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah L.","family":"Patarroyo-White","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vargas","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea","family":"Nagy","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon K.","family":"Powell","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fraser","family":"Wright","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sarkar","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haig H.","family":"Kazazian","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"McClelland","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Couto","sequence":"additional","affiliation":[{"name":"From Avigen Inc., Alameda, CA; and the Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223241424600_REF1","doi-asserted-by":"crossref","unstructured":"Lofqvist T, Nilsson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients\u2014a long-term follow-up. J Intern Med.1997;241: 395-400.","DOI":"10.1046\/j.1365-2796.1997.130135000.x"},{"key":"2020021223241424600_REF2","doi-asserted-by":"crossref","unstructured":"Kaufman RJ. Advances toward gene therapy for hemophilia at the millennium. Hum Gene Ther.1999;10: 2091-2107.","DOI":"10.1089\/10430349950017095"},{"key":"2020021223241424600_REF3","doi-asserted-by":"crossref","unstructured":"Park F, Ohashi K, Kay MA. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood. 2000;96: 1173-1176.","DOI":"10.1182\/blood.V96.3.1173"},{"key":"2020021223241424600_REF4","doi-asserted-by":"crossref","unstructured":"VandenDriessche T, Vanslembrouck V, Goovaerts I, et al. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci U S A. 1999;96: 10379-10384.","DOI":"10.1073\/pnas.96.18.10379"},{"key":"2020021223241424600_REF5","doi-asserted-by":"crossref","unstructured":"Balague C, Zhou J, Dai Y, et al. Sustained highlevel expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood. 2000;95: 820-828.","DOI":"10.1182\/blood.V95.3.820.003k32_820_828"},{"key":"2020021223241424600_REF6","doi-asserted-by":"crossref","unstructured":"Gallo-Penn AM, Shirley PS, Andrews JL, et al. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. Hum Gene Ther.1999; 10: 1791-1802.","DOI":"10.1089\/10430349950017473"},{"key":"2020021223241424600_REF7","doi-asserted-by":"crossref","unstructured":"Gallo-Penn AM, Shirley PS, Andrews JL, et al. Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. Blood. 2001;97: 107-113.","DOI":"10.1182\/blood.V97.1.107"},{"key":"2020021223241424600_REF8","doi-asserted-by":"crossref","unstructured":"Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med.2001;344: 1735-1742.","DOI":"10.1056\/NEJM200106073442301"},{"key":"2020021223241424600_REF9","doi-asserted-by":"crossref","unstructured":"Parker A, Nagy D, Powell S, et al. Preclinical safety testing of AAV-hFIX vecors purified by CsCl centrifugation or column chromatography [abstract]. Mol Ther.2002;5: 262a.","DOI":"10.1016\/S1525-0016(16)43092-3"},{"key":"2020021223241424600_REF10","doi-asserted-by":"crossref","unstructured":"Herzog RW, Yang EY, Couto LB, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med.1999;5: 56-63.","DOI":"10.1038\/4743"},{"key":"2020021223241424600_REF11","doi-asserted-by":"crossref","unstructured":"Mount JD, Herzog RW, Tillson DM, et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood. 2002;99: 2670-2676.","DOI":"10.1182\/blood.V99.8.2670"},{"key":"2020021223241424600_REF12","doi-asserted-by":"crossref","unstructured":"Wang L, Nichols TC, Read MS, Bellinger DA, Verma IM. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther.2000;1: 154-158.","DOI":"10.1006\/mthe.2000.0031"},{"key":"2020021223241424600_REF13","doi-asserted-by":"crossref","unstructured":"Kay MA, Manno CS, Ragni MV, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet.2000;24: 257-261.","DOI":"10.1038\/73464"},{"key":"2020021223241424600_REF14","doi-asserted-by":"crossref","unstructured":"Manno CS, Chew AJ, Hutchison S, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 2003;101: 2963-2972.","DOI":"10.1182\/blood-2002-10-3296"},{"key":"2020021223241424600_REF15","unstructured":"Glader B, Kay MA, Hutchinson S, et al. A phase I trial of AAV mediated, liver-directed gene transfer for hemophilia B. Presented at: The National Hemophilia Foundation's Sixth Workshop on Gene Therapies for Hemophilia; April 25-26, 2003, La Jolla, CA."},{"key":"2020021223241424600_REF16","doi-asserted-by":"crossref","unstructured":"Chao H, Mao L, Bruce AT, Walsh CE. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood. 2000;95: 1594-1599.","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599"},{"key":"2020021223241424600_REF17","doi-asserted-by":"crossref","unstructured":"Burke RL, Pachl C, Quiroga M, et al. The functional domains of coagulation factor VIII:C. J Biol Chem.1986;261: 12574-12578.","DOI":"10.1016\/S0021-9258(18)67127-3"},{"key":"2020021223241424600_REF18","doi-asserted-by":"crossref","unstructured":"Yonemura H, Sugawara K, Nakashima K, et al. Efficient production of recombinant human factor VIII by co-expression of the heavy and light chains. Protein Eng.1993;6: 669-674.","DOI":"10.1093\/protein\/6.6.669"},{"key":"2020021223241424600_REF19","doi-asserted-by":"crossref","unstructured":"Burton M, Nakai H, Colosi P, Cunningham J, Mitchell R, Couto L. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. Proc Natl Acad Sci U S A. 1999;96: 12725-12730.","DOI":"10.1073\/pnas.96.22.12725"},{"key":"2020021223241424600_REF20","doi-asserted-by":"crossref","unstructured":"Miao CH, Ohashi K, Patijn GA, et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther.2000;1: 522-532.","DOI":"10.1006\/mthe.2000.0075"},{"key":"2020021223241424600_REF21","doi-asserted-by":"crossref","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem.1987;162: 156-159.","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"2020021223241424600_REF22","doi-asserted-by":"crossref","unstructured":"Matsushita T, Elliger S, Elliger C, et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther.1998;5: 938-945.","DOI":"10.1038\/sj.gt.3300680"},{"key":"2020021223241424600_REF23","doi-asserted-by":"crossref","unstructured":"Qu G, Sperinde G, Wang X, et al. Characterization of AAV vectors expressing human coaggulation factor IX produced at intermediate scale [abstract]. Mol Ther.2002;5: 146a.","DOI":"10.1016\/S1525-0016(16)42976-X"},{"key":"2020021223241424600_REF24","doi-asserted-by":"crossref","unstructured":"Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet.1995;10: 119-121.","DOI":"10.1038\/ng0595-119"},{"key":"2020021223241424600_REF25","doi-asserted-by":"crossref","unstructured":"Kasper CK, Aledort L, Aronson D, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34: 612.","DOI":"10.1055\/s-0039-1689482"},{"key":"2020021223241424600_REF26","unstructured":"Harlow E, Lane D. Using Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999."},{"key":"2020021223241424600_REF27","unstructured":"Sambrook J, Maniatis T, Fritsch EF. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989."},{"key":"2020021223241424600_REF28","doi-asserted-by":"crossref","unstructured":"Collarini EJ, Nagy D, Cain CA, Gammon D, Schueler PA, Mahoney WC. A novel method for depositing erythroid cells onto glass slides for fetal cell analysis. Cytometry. 2001;45: 304-309.","DOI":"10.1002\/1097-0320(20011201)45:4<304::AID-CYTO10022>3.0.CO;2-#"},{"key":"2020021223241424600_REF29","doi-asserted-by":"crossref","unstructured":"Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol.1987;105: 2665-2674.","DOI":"10.1083\/jcb.105.6.2665"},{"key":"2020021223241424600_REF30","doi-asserted-by":"crossref","unstructured":"Swaroop M, Moussalli M, Pipe SW, Kaufman RJ. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem.1997;272: 24121-24124.","DOI":"10.1074\/jbc.272.39.24121"},{"key":"2020021223241424600_REF31","doi-asserted-by":"crossref","unstructured":"Nakai H, Thomas CE, Storm TA, et al. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J Virol.2002;76: 11343-11349.","DOI":"10.1128\/JVI.76.22.11343-11349.2002"},{"key":"2020021223241424600_REF32","doi-asserted-by":"crossref","unstructured":"Snyder RO, Miao CH, Patijn GA, et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet.1997;16: 270-276.","DOI":"10.1038\/ng0797-270"},{"key":"2020021223241424600_REF33","doi-asserted-by":"crossref","unstructured":"Bi L, Sarkar R, Naas T, et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood. 1996;88: 3446-3450.","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446"},{"key":"2020021223241424600_REF34","doi-asserted-by":"crossref","unstructured":"Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther.1996;7: 2101-2112.","DOI":"10.1089\/hum.1996.7.17-2101"},{"key":"2020021223241424600_REF35","doi-asserted-by":"crossref","unstructured":"Duan D, Sharma P, Yang J, et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol.1998;72: 8568-8577.","DOI":"10.1128\/JVI.72.11.8568-8577.1998"},{"key":"2020021223241424600_REF36","doi-asserted-by":"crossref","unstructured":"Duan D, Yue Y, Yan Z, Engelhardt JF. A new dualvector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat Med.2000;6: 595-598.","DOI":"10.1038\/75080"},{"key":"2020021223241424600_REF37","doi-asserted-by":"crossref","unstructured":"Sun L, Li J, Xiao X. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med.2000;6: 599-602.","DOI":"10.1038\/75087"},{"key":"2020021223241424600_REF38","doi-asserted-by":"crossref","unstructured":"Yan Z, Zhang Y, Duan D, Engelhardt JF. Transsplicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci U S A. 2000;97: 6716-6721.","DOI":"10.1073\/pnas.97.12.6716"},{"key":"2020021223241424600_REF39","doi-asserted-by":"crossref","unstructured":"Nakai H, Storm TA, Kay MA. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotechnol.2000;18: 527-532.","DOI":"10.1038\/75390"},{"key":"2020021223241424600_REF40","doi-asserted-by":"crossref","unstructured":"Chao H, Sun L, Bruce A, Xiao X, Walsh CE. Expression of human factor VIII by splicing between dimerized AAV vectors. Mol Ther.2002;5: 716-722.","DOI":"10.1006\/mthe.2002.0607"},{"key":"2020021223241424600_REF41","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1985. NIH publication no. 85-23."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/12\/3919\/1692302\/h82303003919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/12\/3919\/1692302\/h82303003919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T02:26:11Z","timestamp":1623205571000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/12\/3919\/16726\/Phenotypic-correction-of-a-mouse-model-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-01-0222","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}